Clinical outcomes in non‐small‐cell lung cancer patients with EGFR mutations: pooled analysis

L Paz‐Ares, D Soulières, I Melezínek… - Journal of cellular …, 2010 - Wiley Online Library
Introduction• Literature review‐Molecular biology of EGFR mutations‐Clinical characteristics
of NSCLC patients with EGFR mutations‐Genetic characteristics of EGFR‐mutated tumours …

[引用][C] Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: Pooled analysis

L Paz-Ares, D Soulières… - Journal of Cellular …, 2010 - produccioncientifica.ucm.es

Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis.

L Paz-Ares, D Soulières, I Melezínek… - Journal of Cellular …, 2010 - search.ebscohost.com
Introduction• Literature review-Molecular biology of EGFR mutations-Clinical characteristics
of NSCLC patients with EGFR mutations-Genetic characteristics of EGFR-mutated tumours …

Clinical outcomes in non‐small‐cell lung cancer patients with EGFR mutations: pooled analysis

L Paz‐Ares, D Soulières, I Melezínek… - Journal of Cellular …, 2010 - search.proquest.com
Conclusions Non‐small‐cell lung cancer (NSCLC) with mutations in the epidermal growth
factor receptor (EGFR) is a distinct subgroup of NSCLCs that is particularly responsive to …

[PDF][PDF] Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis

L Paz-Ares, D Soulières, I Melezínek, J Moecks, L Keil… - J. Cell. Mol. Med, 2009 - Citeseer
Non-small-cell lung cancer (NSCLC) with mutations in the epidermal growth factor receptor
(EGFR) is a distinct subgroup of NSCLCs that is particularly responsive to EGFR tyrosine …

[PDF][PDF] Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis

L Paz-Ares, D Soulières, I Melezínek, J Moecks… - J. Cell. Mol …, 2009 - academia.edu
Non-small-cell lung cancer (NSCLC) with mutations in the epidermal growth factor receptor
(EGFR) is a distinct subgroup of NSCLCs that is particularly responsive to EGFR tyrosine …

[引用][C] Clinical outcomes in non‐small‐cell lung cancer patients with EGFR mutations: pooled analysis

L Paz‐Ares, D Soulières, I Melezínek… - Journal of Cellular and …, 2010 - cir.nii.ac.jp
Clinical outcomes in non‐small‐cell lung cancer patients with <i>EGFR</i> mutations: pooled
analysis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

[HTML][HTML] Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis

L Paz-Ares, D Soulières, I Melezínek… - Journal of Cellular …, 2010 - ncbi.nlm.nih.gov
Non-small-cell lung cancer (NSCLC) with mutations in the epidermal growth factor receptor
(EGFR) is a distinct subgroup of NSCLCs that is particularly responsive to EGFR tyrosine …

Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis

L Paz-Ares, D Soulières, I Melezínek… - Journal of cellular …, 2010 - pubmed.ncbi.nlm.nih.gov
Non-small-cell lung cancer (NSCLC) with mutations in the epidermal growth factor receptor
(EGFR) is a distinct subgroup of NSCLCs that is particularly responsive to EGFR tyrosine …

Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis.

L Paz-Ares, D Soulières, I Melezínek… - Journal of Cellular …, 2009 - europepmc.org
Non-small-cell lung cancer (NSCLC) with mutations in the epidermal growth factor receptor
(EGFR) is a distinct subgroup of NSCLCs that is particularly responsive to EGFR tyrosine …